Executive Search Success Story: Building Executive Leadership for an Ultra-Rare Gene Therapy Company

How JRG Partners built the executive, scientific, and clinical leadership team behind a venture-backed gene therapy company advancing ultra-rare disease programs toward pivotal trials — recruiting across eight leadership mandates through a confidential search.

The Challenge

A venture-backed biotechnology company focused on gene therapies for ultra-rare diseases was advancing multiple clinical programs toward pivotal trials. As investor expectations increased and regulatory milestones approached, leadership recognized the need for experienced executives capable of guiding scientific innovation through commercialization. Leadership identified several pressures:

• Shortage of executives with gene therapy and rare disease experience
• Increasing regulatory complexity across global markets
• Need for commercialization planning well before product approval
• Competition for specialized biotech leadership talent
• Succession concerns within scientific and clinical leadership functions
• Demand for leaders capable of managing rapid organizational growth

The executive team determined that multiple strategic hires would be required to support long-term objectives. The confidential mandate covered a Chief Executive Officer, Chief Scientific Officer, Chief Development Officer, VP Clinical Operations, VP Regulatory Affairs, Head of Medical Affairs, Commercial Strategy Leaders, and Patient Advocacy Executives. The organization required a search partner with deep expertise in biotechnology, gene therapy, and rare disease leadership recruitment.

Why They Chose JRG Partners

After evaluating several executive search firms, the client selected JRG Partners for four reasons:

Specialized Biotech Recruitment Expertise

JRG Partners maintains dedicated executive search practices focused on biotechnology, life sciences, clinical development, gene therapy, and executive leadership.

Access to High-Demand Scientific Talent

Many of the industry’s most accomplished biotech leaders are deeply engaged in ongoing programs and not actively pursuing new opportunities. JRG Partners leveraged extensive industry networks to identify exceptional passive candidates.

Understanding of Rare Disease Development

The client required leaders capable of managing scientific innovation, clinical strategy, regulatory engagement, and commercialization planning within highly specialized therapeutic areas.

Global Talent Reach

The search targeted executives from major biotechnology markets including Boston, San Diego, San Francisco, Cambridge, London, Zurich, Basel, and Singapore.

Our Executive Search Strategy

Phase 1 — Organizational Assessment

Our consultants partnered with founders, investors, and executive leadership to identify development objectives, clinical-program priorities, leadership-capability gaps, regulatory requirements, succession-planning concerns, and future organizational needs. This assessment enabled development of executive profiles aligned with long-term strategic goals.

Phase 2 — Talent Mapping

JRG Partners conducted a comprehensive market analysis covering rare disease biotech companies, gene therapy organizations, specialty pharmaceutical firms, research-focused biotechnology companies, public life sciences companies, venture-backed biotech businesses, and global pharmaceutical innovators. More than 500 executive profiles were evaluated worldwide.

Phase 3 — Executive Engagement

Using a research-driven methodology, our consultants engaged leaders with proven success in clinical development, gene therapy programs, regulatory strategy, product-launch planning, medical affairs leadership, investor-facing executive roles, organizational-growth initiatives, and patient-engagement programs. Only candidates with measurable success and strong cultural alignment advanced.

Phase 4 — Assessment & Selection

Each finalist underwent rigorous evaluation focused on scientific leadership expertise, clinical-development experience, strategic-thinking capabilities, regulatory knowledge, stakeholder-engagement skills, team-leadership effectiveness, cultural fit, and long-term leadership potential.